AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 
SANTA FE, N.M., April 18, 2016 -- Sigma Labs, Inc. (OTCQB:SGLB) (“Sigma Labs” or the “Company”), a developer of advanced, in process, non-destructive quality inspection systems for metal-based additive manufacturing (“AM”) and other advanced manufacturing technologies, today announced that the Company is teaming with Spartacus3D, a unit of France’s Farinia Group, to accelerate its presence in Europe. As part of this agreement, Spartacus3D will serve as a demonstration, test and evaluation site for Sigma Labs’ PrintRite3D® commercialization and market adoption activities in Europe.
“This is an exciting development that builds on our existing relationship with Spartacus3D,” said Mark Cola, President & CEO of Sigma Labs. “We previously announced that Spartacus3D, a leading French AM service provider, had signed up for our Early Adopter Program in 2015; since then, they have fully installed our software and now use it regularly. This new agreement strengthens our partnership and, essentially, makes Spartacus3D our showcase site in Europe. We’ll work together to expand the use of our PrintRite3D® technology as we concurrently build a sales and support presence throughout the continent. While Sigma Labs is already well known in North America, our recent steps – both in Europe and Asia – will help build our brand globally and accelerate top line growth.”
About Sigma Labs, Inc.
Sigma Labs, Inc. develops and engineers advanced, in-process, non-destructive quality inspection systems for commercial firms worldwide seeking productive solutions for metal-based additive manufacturing or 3D printing, and other advanced manufacturing technologies. For more information please visit www.sigmalabsinc.com.
About Spartacus3D
Spartacus3D, the additive manufacturing division of the Farinia Group, offers engineering, consulting, and contract additive manufacturing services to a host of industries, with customers throughout Europe. The company manufactures components with high-quality metal powder through selective laser melting. For more information please visit http://www.farinia.com/companies/spartacus3d.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "expects," "anticipates," "intends," "believes" or "will." These forward-looking statements are subject to a number of risks, uncertainties and assumptions that could adversely affect us, including the risks set forth in Sigma Labs' most recent annual report on Form 10-K. The forward-looking statements in this press release are made only as of the date of this press release. Sigma Labs undertakes no obligation to update any of these forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact: Chris Witty [email protected] 646-438-9385
